Veranex is acquiring Experien Group to provide comprehensive consulting services to medtech companies. This move is expected to bolster Veranex’s consulting portfolio and will improve all aspects of the product lifecycle for its clients.
Veranex CEO David Dockhorn remarks, “We are excited to welcome Experien Group to Veranex,” adding, “With this acquisition, Veranex adds the premier provider of regulatory, quality, and clinical consulting services to medtech companies. Veranex’s clients will benefit from Experien’s long-standing FDA engagement, well-established global regulatory guidance experience, and a demonstrated track record of successful approvals.” Read more here.
(Source: Veranex, 8/3/21)